| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000023350 |
| Receipt No. | R000026315 |
| Official scientific title of the study | Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors |
| Date of disclosure of the study information | 2016/07/27 |
| Last modified on | 2016/10/18 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors | |
| Title of the study (Brief title) | Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors | |
| Region |
|
|
| Condition | |||
| Condition | digestive malignant tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | We examine the utility of endoscopic detection for digestive malignant tumors by using protoporphyrin IX fluorescence and endemism spectral detection, which accumulates selectively after 5-ALA administration. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The detection rate for malignant tumors by using protoporphyrin IX fluorescence and endemism spectral detection |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | 2days | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Age of patients at start of the trial is 20 years or older
2) Patients with digestive malignant tumors with the need of pathological diagnosis before treatment |
|||
| Key exclusion criteria | 1) Patients with porphyrinemia
2) Patients with hypersensitivity or a medical history with porphyrin related adverse events 3) People who have taken chemotheraphy for malignant tumors within one month before the start of the trial 4) Patients who have had other cancers 5) Patients who are taking anticoagulant or antithrombotic drugs 6) Women who are pregnant or are possibly pregnant 7) Patients with positive HBs antigen or HCV antibody |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuya Matsumoto |
| Organization | Department of Multidisciplinary Internal Medicine Faculty of Medicine,Tottori University |
| Division name | Division of Medicine and Clinical Science |
| Address | 36-1 Nishi-cho, Yonago 683-8504, Japan. |
| TEL | 0859-38-6527 |
| matsumot@med.tottori-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroki Kurumi |
| Organization | Department of Multidisciplinary Internal Medicine Faculty of Medicine,Tottori University |
| Division name | Division of Medicine and Clinical Science |
| Address | 36-1 Nishi-cho, Yonago 683-8504, Japan. |
| TEL | 0859-38-6527 |
| Homepage URL | |
| kurumi_1022_1107@yahoo.co.jp | |
| Sponsor | |
| Institute | Tottori University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026315 |